Literature DB >> 26169275

Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice.

Parna Bhattacharya1, Ranadhir Dey1, Pradeep K Dagur2, Michael Kruhlak3, Nevien Ismail1, Alain Debrabant1, Amritanshu B Joshi1, Adovi Akue4, Mark Kukuruga4, Kazuyo Takeda4, Angamuthu Selvapandiyan5, John Philip McCoy2, Hira L Nakhasi6.   

Abstract

Visceral leishmaniasis (VL) causes significant mortality and there is no effective vaccine. Previously, we have shown that genetically modified Leishmania donovani parasites, here described as live attenuated parasites, induce a host protective adaptive immune response in various animal models. In this study, we demonstrate an innate immune response upon infection with live attenuated parasites in macrophages from BALB/c mice both in vitro and in vivo. In vitro infection of macrophages with live attenuated parasites (compared to that with wild-type [WT] L. donovani parasites) induced significantly higher production of proinflammatory cytokines (tumor necrosis factor alpha [TNF-α], interleukin-12 [IL-12], gamma interferon [IFN-γ], and IL-6), chemokines (monocyte chemoattractant protein 1/CCL-2, macrophage inflammatory protein 1α/CCL-3, and IP-10), reactive oxygen species (ROS), and nitric oxide, while concomitantly reducing anti-inflammatory cytokine IL-10 and arginase-1 activities, suggesting a dominant classically activated/M1 macrophage response. The classically activated response in turn helps in presenting antigen to T cells, as observed with robust CD4(+) T cell activation in vitro. Similarly, parasitized splenic macrophages from live attenuated parasite-infected mice also demonstrated induction of an M1 macrophage phenotype, indicated by upregulation of IL-1β, TNF-α, IL-12, and inducible nitric oxide synthase 2 and downregulation of genes associated with the M2 phenotype, i.e., the IL-10, YM1, Arg-1, and MRC-1 genes, compared to WT L. donovani-infected mice. Furthermore, an ex vivo antigen presentation assay showed macrophages from live attenuated parasite-infected mice induced higher IFN-γ and IL-2 but significantly less IL-10 production by ovalbumin-specific CD4(+) T cells, resulting in proliferation of Th1 cells. These data suggest that infection with live attenuated parasites promotes a state of classical activation (M1 dominant) in macrophages that leads to the generation of protective Th1 responses in BALB/c mice.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26169275      PMCID: PMC4567628          DOI: 10.1128/IAI.00184-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  69 in total

Review 1.  Alternatively activated macrophages during parasite infections.

Authors:  Wim Noël; Geert Raes; Gholamreza Hassanzadeh Ghassabeh; Patrick De Baetselier; Alain Beschin
Journal:  Trends Parasitol       Date:  2004-03

2.  Biochemical and functional characterization of three activated macrophage populations.

Authors:  Justin P Edwards; Xia Zhang; Kenneth A Frauwirth; David M Mosser
Journal:  J Leukoc Biol       Date:  2006-08-11       Impact factor: 4.962

3.  Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo.

Authors:  Pascale Kropf; José M Fuentes; Eva Fähnrich; Luis Arpa; Shanthi Herath; Verena Weber; Germán Soler; Antonio Celada; Manuel Modolell; Ingrid Müller
Journal:  FASEB J       Date:  2005-04-05       Impact factor: 5.191

4.  The Recombinant BCG ΔureC::hly Vaccine Targets the AIM2 Inflammasome to Induce Autophagy and Inflammation.

Authors:  Hiroyuki Saiga; Natalie Nieuwenhuizen; Martin Gengenbacher; Anne-Britta Koehler; Stefanie Schuerer; Pedro Moura-Alves; Ina Wagner; Hans-Joachim Mollenkopf; Anca Dorhoi; Stefan H E Kaufmann
Journal:  J Infect Dis       Date:  2014-12-11       Impact factor: 5.226

5.  Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.

Authors:  Jacqueline Araújo Fiuza; Sreenivas Gannavaram; Helton da Costa Santiago; Angamuthu Selvapandiyan; Daniel Menezes Souza; Lívia Silva Araújo Passos; Ludmila Zanandreis de Mendonça; Denise da Silveira Lemos-Giunchetti; Natasha Delaqua Ricci; Daniella Castanheira Bartholomeu; Rodolfo Cordeiro Giunchetti; Lilian Lacerda Bueno; Rodrigo Correa-Oliveira; Hira L Nakhasi; Ricardo Toshio Fujiwara
Journal:  Vaccine       Date:  2014-12-01       Impact factor: 3.641

6.  Leishmania major-parasitized macrophages augment Th2-type T cell activation.

Authors:  H R Chakkalath; R G Titus
Journal:  J Immunol       Date:  1994-11-15       Impact factor: 5.422

Review 7.  Live attenuated Leishmania vaccines: a potential strategic alternative.

Authors:  Ricardo Silvestre; Anabela Cordeiro-da-Silva; Ali Ouaissi
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008-03-31       Impact factor: 4.291

8.  Liposomal cholesterol delivery activates the macrophage innate immune arm to facilitate intracellular Leishmania donovani killing.

Authors:  June Ghosh; Rajan Guha; Shantanabha Das; Syamal Roy
Journal:  Infect Immun       Date:  2013-11-25       Impact factor: 3.441

9.  Activation of p38 mitogen-activated protein kinase attenuates Leishmania donovani infection in macrophages.

Authors:  Muthoni Junghae; John G Raynes
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

10.  Vaccine Development Against Leishmania donovani.

Authors:  Amrita Das; Nahid Ali
Journal:  Front Immunol       Date:  2012-05-15       Impact factor: 7.561

View more
  26 in total

1.  Live Attenuated Leishmania donovani Centrin Gene-Deleted Parasites Induce IL-23-Dependent IL-17-Protective Immune Response against Visceral Leishmaniasis in a Murine Model.

Authors:  Antara Banerjee; Parna Bhattacharya; Pradeep K Dagur; Subir Karmakar; Nevien Ismail; Amritanshu B Joshi; Adovi D Akue; Mark KuKuruga; John Philip McCoy; Ranadhir Dey; Hira L Nakhasi
Journal:  J Immunol       Date:  2017-11-29       Impact factor: 5.422

Review 2.  Using proteomics as a powerful tool to develop a vaccine against Mediterranean visceral leishmaniasis.

Authors:  Sajad Rashidi; Kurosh Kalantar; Gholamreza Hatam
Journal:  J Parasit Dis       Date:  2018-03-19

3.  Plasmodium falciparum Antigen Expression in Leishmania Parasite: A Way Forward for Live Attenuated Vaccine Development.

Authors:  Akriti Srivastava; Swati Garg; Sweta Karan; Shikha Kaushik; Anand Ranganathan; Soumya Pati; Lalit C Garg; Shailja Singh
Journal:  Methods Mol Biol       Date:  2022

4.  Influence of genetic variants of gamma interferon, interleukins 10 and 12 on Visceral Leishmaniasis in an endemic area, Iran.

Authors:  Mehdi Kalani; Maral Choopanizadeh; Manoochehr Rasouli
Journal:  Pathog Glob Health       Date:  2019-01-15       Impact factor: 2.894

5.  Essential Role of Neutrophils in the Protective Immune Response Induced by a Live Attenuated Leishmania Vaccine.

Authors:  Parna Bhattacharya; Ranadhir Dey; Ankit Saxena; Subir Karmakar; Nevien Ismail; Sreenivas Gannavaram; Pradeep K Dagur; Monika Satoskar; Sanika Satoskar; Silvia De Paoli; Kazuyo Takeda; John Philip McCoy; Hira L Nakhasi
Journal:  J Immunol       Date:  2020-11-11       Impact factor: 5.422

Review 6.  The History of Live Attenuated Centrin Gene-Deleted Leishmania Vaccine Candidates.

Authors:  Greta Volpedo; Parna Bhattacharya; Sreenivas Gannavaram; Thalia Pacheco-Fernandez; Timur Oljuskin; Ranadhir Dey; Abhay R Satoskar; Hira L Nakhasi
Journal:  Pathogens       Date:  2022-04-02

Review 7.  Possibilities and challenges for developing a successful vaccine for leishmaniasis.

Authors:  Saumya Srivastava; Prem Shankar; Jyotsna Mishra; Sarman Singh
Journal:  Parasit Vectors       Date:  2016-05-12       Impact factor: 3.876

8.  A Chimera of Th1 Stimulatory Proteins of Leishmania donovani Offers Moderate Immunotherapeutic Efficacy with a Th1-Inclined Immune Response against Visceral Leishmaniasis.

Authors:  Sneha Ratnapriya; Narendra Kumar Yadav; Anuradha Dube; Amogh Anant Sahasrabuddhe
Journal:  Biomed Res Int       Date:  2021-02-27       Impact factor: 3.411

9.  Genetic Manipulation of Leishmania donovani to Explore the Involvement of Argininosuccinate Synthase in Oxidative Stress Management.

Authors:  Abul Hasan Sardar; Armando Jardim; Ayan Kumar Ghosh; Abhishek Mandal; Sushmita Das; Savita Saini; Kumar Abhishek; Ruby Singh; Sudha Verma; Ajay Kumar; Pradeep Das
Journal:  PLoS Negl Trop Dis       Date:  2016-03-03

10.  Gene deleted live attenuated Leishmania vaccine candidates against visceral leishmaniasis elicit pro-inflammatory cytokines response in human PBMCs.

Authors:  Kumar Avishek; Himanshu Kaushal; Sreenivas Gannavaram; Ranadhir Dey; Angamuthu Selvapandiyan; V Ramesh; Narender Singh Negi; Uma S Dubey; Hira L Nakhasi; Poonam Salotra
Journal:  Sci Rep       Date:  2016-09-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.